MedTrace Logo

The Effects of Virtual Reality Based Exercises in Patients With Adhesive Capsulitis

NCT05961033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-09-03

No results posted yet for this study

Summary

Musculoskeletal disorders such as adhesive capsulitis (AC) affect tissues such as muscles, bones, joints, tendons and ligaments and are the second most disabling condition worldwide. Musculoskeletal Systemic disorders are typically characterized by pain, limitations in joint range of motion or functional ability.

Existing studies have shown that Virtual Reality (VR) is beneficial in pain management for example; pain relief during dressing changes in burn patients. VR can also reduce anxiety, distract from the fear of pain, and reduce stress. It can distract the patients who are afraid of moving due to pain and enable them to move freely. In this study, AC patients will be treated with VR application. Patients pain levels, upper extremity range of motion, functional activity levels and quality of life levels will be evaluated. A total of 36 patients will be included in the study.

This observational randomized controlled study will contribute to the literature by investigating the effects of VR based exercises in individuals with AC.

Conditions

  • Pain
  • Quality of Life
  • Range of Motion
  • Virtual Reality

Interventions

DEVICE

Virtual Reality based exercises

Play VR games

Sponsors & Collaborators

  • Sakarya University of Applied Sciences

    collaborator UNKNOWN

  • Kocaeli University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-11-01
Completion
2023-12-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05961033 on ClinicalTrials.gov